DE3579847D1 - Medikamente welche die freifliessenden eigenschaften von blut verbessern und die verwendung in therapeutika. - Google Patents

Medikamente welche die freifliessenden eigenschaften von blut verbessern und die verwendung in therapeutika.

Info

Publication number
DE3579847D1
DE3579847D1 DE8585401072T DE3579847T DE3579847D1 DE 3579847 D1 DE3579847 D1 DE 3579847D1 DE 8585401072 T DE8585401072 T DE 8585401072T DE 3579847 T DE3579847 T DE 3579847T DE 3579847 D1 DE3579847 D1 DE 3579847D1
Authority
DE
Germany
Prior art keywords
therapeutics
medicines
blood
free
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585401072T
Other languages
English (en)
Inventor
Jean-Claude Lormeau
Maurice Petitou
Jean Choay
Francis Toulemonde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Application granted granted Critical
Publication of DE3579847D1 publication Critical patent/DE3579847D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585401072T 1984-05-30 1985-05-30 Medikamente welche die freifliessenden eigenschaften von blut verbessern und die verwendung in therapeutika. Expired - Lifetime DE3579847D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR848408570A FR2568774B2 (fr) 1984-05-30 1984-05-30 Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique

Publications (1)

Publication Number Publication Date
DE3579847D1 true DE3579847D1 (de) 1990-10-31

Family

ID=9304580

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585401072T Expired - Lifetime DE3579847D1 (de) 1984-05-30 1985-05-30 Medikamente welche die freifliessenden eigenschaften von blut verbessern und die verwendung in therapeutika.

Country Status (4)

Country Link
US (1) US4777161A (de)
EP (1) EP0163582B1 (de)
DE (1) DE3579847D1 (de)
FR (1) FR2568774B2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
EP0300099A1 (de) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide
EP0337327A1 (de) * 1988-04-09 1989-10-18 Bioiberica, S.A. Verfahren zur Herstellung von neuen Oligosaccharid-Fragmenten durch kontrollierte chemische Depolymerisation von Heparin
WO1990001332A1 (en) * 1988-08-10 1990-02-22 Cetus Corporation Plasminogen activator-heparin conjugates
US5130143A (en) * 1988-11-04 1992-07-14 The Research Foundation Of State University Of New York Use of a low affinity-heparin fraction in conjunction with t-pa for thrombolytic therapy
US5646130A (en) * 1995-06-30 1997-07-08 Ocean University Of Oingdao Low molecular weight sulfated polysaccharides and uses thereof
HUP0201712A3 (en) * 1999-06-30 2003-03-28 Weitz Jeffrey I Ancaster Clot associated coagulation factors inhibiting heparin compositions
AU2001291549A1 (en) * 2000-09-08 2002-03-22 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
MXPA03005393A (es) * 2000-12-19 2003-09-25 Merck Patent Gmbh Formulacion farmaceutica que contiene pirazolo (4,3-d) pirimidinas y antitromboticos, antagonistas de calcio, prostaglandinas o derivados de prostaglandina.
KR20030059351A (ko) * 2000-12-19 2003-07-07 메르크 파텐트 게엠베하 티에노피리미딘 및 항혈전제, 칼슘 길항제,프로스타글란딘 또는 프로스타글란딘 유도체를 포함하여이루어지는 약제학적 조성물
CA2431147A1 (en) * 2000-12-19 2002-06-27 Merck Patent Gesellschaft Mit Beschraenkter Haftung Pharmaceutical formulation comprising thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
WO2003018032A1 (en) * 2001-08-28 2003-03-06 Leo Pharma A/S Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154822A (en) * 1976-08-02 1979-05-15 The University Of Chicago Polysaccharide for enhancement of cardiac output
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
FR2440376A1 (fr) * 1978-11-06 1980-05-30 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
SE449753B (sv) * 1978-11-06 1987-05-18 Choay Sa Mukopolysackaridkomposition med reglerande verkan pa koagulation, lekemedel innehallande densamma samt forfarande for framstellning derav

Also Published As

Publication number Publication date
EP0163582A3 (en) 1987-04-08
EP0163582B1 (de) 1990-09-26
FR2568774A2 (fr) 1986-02-14
US4777161A (en) 1988-10-11
EP0163582A2 (de) 1985-12-04
FR2568774B2 (fr) 1989-05-19

Similar Documents

Publication Publication Date Title
DE69016348D1 (de) Leukozyten und Hämoglobin im Blut.
DE3579847D1 (de) Medikamente welche die freifliessenden eigenschaften von blut verbessern und die verwendung in therapeutika.
DE3583392D1 (de) Carbonatapatit enthaltendes mittel und die verwendung von carbonatapatit fuer implantate.
DE3781214D1 (de) Lenkbarer und ausrichtbarer katheter.
FR2591103B1 (fr) Composition cosmetique pour la coloration de la peau renfermant de l'aldehyde mesotartrique et une ou plusieurs hydroxyquinones et procede de coloration de la peau avec cette composition.
ATE101856T1 (de) Chlorination von carbohydraten und anderen alkoholen.
DE3582731D1 (de) Lenkbarer und ausrichtbarer katheter.
DE3687646D1 (de) Biosensor und dessen herstellung.
DE69008664T2 (de) Bestrahlung von bluterzeugnissen.
DE3676858D1 (de) Schnecken-extruder oder -kneter und dessen schnecke.
DE3877428D1 (de) Kondensationsprodukte von silanol, deren herstellung und verwendungen.
DE3584370D1 (de) Verwendung von podophyllotoxin und dessen derivaten.
DE3671913D1 (de) Waessrige klebstoffe und deren verwendung.
ZA884486B (en) Promoters for the expression of foreign dna in methylotrophic bacteria,the obtaining thereof and the use thereof
DE3682882D1 (de) Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung.
IT8421199A1 (it) "Elemento per costruzioni, procedimento per la sua fabbricazione ed utilizzazione dell'elemento per costruzione".
DE58901122D1 (de) Verwendung von tnf und lt zur herstellung von arzneimitteln.
DE69000718D1 (de) Sinterprodukt aus titan- und antimonoxid.
DE3586247T2 (de) Hochfester rostfreistahl und dessen herstellung.
DE69011565D1 (de) Herstellung von Pre-Kaseinaten und Verwendung.
DE3687448D1 (de) Verwendung von 6h-7,8-dihydrothiapyrano(3,2d)pyrimidinen zur herstellung von arzneimitteln zur verwendung als hypoglykaemische mittel oder als abmagerungsmittel fuer fettsuechtige patienten.
ATE74763T1 (de) Verwendung von tnf und lt zur herstellung von arzneimitteln.
ATE49021T1 (de) Herstellung von metallischen titan in form von schwamm und vorrichtung dafuer.
RO88838A2 (ro) Produs folosit in tratamentul unor dermatoze
IT8685595A0 (it) Procedimento per la fabbricazione di raccordi in ferro e prodotto ottenuto con tale procedimento.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: BEETZ SEN., R., DIPL.-ING. BEETZ JUN., R., DIPL.-ING. DR.-ING. TIMPE, W., DR.-ING. SIEGFRIED, J., DIPL.-ING. SCHMITT-FUMIAN, W., PROF. DIPL.-CHEM. DR.RER.NAT. MAYR, C., DIPL.-PHYS.DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR